Optiver Holding’s CONMED CNMD Stock Holding History

Optiver Holding’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-164	Closed	-$7.71K	–	2565
2025 Q3	$7.71K	Buy	+164	New	+$8.5K	﹤0.01%	1456

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Optiver Holding's CNMD Position: Q4 2025 in Review

Optiver Holding sold out of CONMED (CNMD) in Q4 2025, closing a stake of 164 shares — an estimated $7.71K sold.

Optiver Holding first reported a position in CNMD in Q3 2025 and held it in 1 quarter. The position peaked at $7.71K in Q3 2025. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

Optiver Holding reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
Optiver Holding sold 164 CONMED shares in Q4 2025, an estimated $7.71K.
Optiver Holding first reported a position in CONMED in Q3 2025 and held it in 1 quarter.
Optiver Holding's CONMED position peaked at $7.71K in Q3 2025.
265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Optiver Holding's 13F filing for Q4 2025, filed 17 Feb 2026.